Adherence to Chronic Disease Medications among New York City Medicaid Participants
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Medication adherence is critical for cardiovascular disease prevention and control. Local health departments are well positioned to address adherence issues, however relevant baseline data and a mechanism for monitoring impact of interventions are lacking. We performed a retrospective analysis using New York State Medicaid claims from 2008 to 2009 to describe rates and predictors of adherence among New York City Medicaid participants with dyslipidemia, diabetes, or hypertension. Adherence was measured using the medication possession ratio, and multivariable logistic regression was used to assess factors related to adherence. Medication regimen adherence was 63%. Greater adherence was observed in those who were older, male, and taking medications from ≥3 drug classes. Compared with whites, blacks and Hispanics were less likely to be adherent (adjusted odds ratio [OR]=0.67, 95% confidence interval [CI]: 0.65–0.70 and adjusted OR=0.76, 95% CI: 0.73–0.78, respectively), while Asians were as likely. Medication adherence was inadequate and racial disparities were identified in NYC Medicaid participants on stable medication regimens for chronic disease. This study demonstrates a claims-based model that may be used by local health departments to monitor and evaluate efforts to improve adherence and reduce disparities.
- Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. [Review] [79 refs]. Circulation. 2009; 119(23): 3028–35. CrossRef
- Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Svc Res. 2007; 7: 175. CrossRef
- Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 1993; 8(6): 306–10. CrossRef
- Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011; 171(9): 814–22. CrossRef
- Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. New Engl J Med. 2010; 362(17): 1553–5. CrossRef
- Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000; 40(2): 157–65.
- Center for Medicare and Medicaid Services. 2011 Medicare Part D Medication Therapy (MTM) Programs. Available at: http://www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet2011063011Final.pdf. Accessed 1 May 2012
- Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50(1): 105–16. CrossRef
- Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988; 26(8): 814–23. CrossRef
- Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care. 2002; 40(12): 1294–300. CrossRef
- Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006; 47(6): 1039–48. CrossRef
- Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165(10): 1147–52. CrossRef
- Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487–97. CrossRef
- Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010; 25(6): 495–503. CrossRef
- Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010; 25(11): 1172–7. CrossRef
- Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010; 48(3) 196–202.
- Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc. 2009; 101(1): 34–9.
- Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006; 98(7): 1071–7.
- Adherence to Chronic Disease Medications among New York City Medicaid Participants
Journal of Urban Health
Volume 90, Issue 2 , pp 323-328
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Medication adherence
- Health disparities
- Cardiovascular prevention
- Public health
- Author Affiliations
- 1. Department of Population Health, New York University School of Medicine, New York, NY, USA
- 2. New York State Department of Health, Albany, NY, USA
- 3. New York City Department of Health and Mental Hygiene, New York, NY, USA
- 4. Centers for Disease Control and Prevention, Atlanta, GA, USA